Scientist Home Future Health Limited (SHFH)

8.00 +1.27% (+0.10)

Over 6M: +344.4%

2026-08-28
2 4 6 8
May Jun Jul Aug

Financials Quarterly

Q3 '24 — Operating Cash Flow: -9.5K Q3 '24 — Net Income: 175 Q3 '24 — Revenue: 59.4K Q3 '24 — Net Income: 175 Q4 '24 — Operating Cash Flow: 8.7K Q4 '24 — Net Income: -15.2K Q1 '25 — Revenue: 44.8K Q1 '25 — Operating Cash Flow: -4.8K Q1 '25 — Net Income: 6.1K Q2 '25 — Revenue: 31.6K Q2 '25 — Operating Cash Flow: -5.3K Q2 '25 — Net Income: -37.2K Q3 '25 — Revenue: 39.6K Q3 '25 — Operating Cash Flow: -99.3K Q3 '25 — Net Income: -47.8K Q4 '25 — Revenue: 88.1K Q4 '25 — Operating Cash Flow: -138.8K Q4 '25 — Net Income: -152.7K Q1 '26 — Revenue: 182.3K Q1 '26 — Operating Cash Flow: -71.8K Q1 '26 — Net Income: -102.1K Q2 '26 — Revenue: 82.9K Q2 '26 — Operating Cash Flow: -12.8K Q2 '26 — Net Income: -97.9K -140K -70K 0 70K 140K 210K
Q3 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0
OE margin -99.2%
Oper. margin -99.9%
Accruals -14.7%
Gross margin 34.1%
EBITDA margin -99.5%
FCF margin -99.2%
OCF margin -80.6%
Profit margin -99.9%
ROA -75.6%
ROCE -211.3%
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.7
ND/EBITDA —
Cash runway 0.023 yr
Current ratio 0.37×
Debt payback 0.0 yr
Quick ratio 0.27×
Cash / Debt —
Debt / Eq —
Equity / Assets —
F-score —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales Q/Q +167.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales/sh Y/Y —
Shares change —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.